Загрузка...
Neurotoxic manifestations of high-dose intrathecal gadolinium administration for CT myelogram
Use of intrathecal gadolinium for contrast-enhanced myelography and cisternography remains off-label and is currently not FDA-approved. We report a 70-year-old male who underwent CT myelogram utilizing off-label high-dose intrathecal gadolinium who developed altered mental status and bilateral heari...
Сохранить в:
| Опубликовано в: : | Radiol Case Rep |
|---|---|
| Главные авторы: | , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Elsevier
2020
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7452073/ https://ncbi.nlm.nih.gov/pubmed/32874398 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.radcr.2020.07.084 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|